West Pharmaceutical Services (WST)

Long-Term Debt

$291.20M

Quarterly · Period ending: · USD

WST logo

WST Long-Term Debt

Latest reported$291.20M
WST Quarterly Long-Term Debt ($26.00M → $291.20M)
High-resolution chart · PNG

WST long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
291,200,000
294,800,000
298,400,000
276,200,000
282,400,000
281,400,000
284,400,000
284,900,000
157,500,000
155,200,000
157,300,000
235,100,000
292,900,000
296,000,000
299,700,000
284,400,000
278,000,000
277,200,000
271,800,000
263,300,000
307,800,000
309,700,000
313,300,000
313,300,000
314,800,000
315,600,000
317,400,000
258,600,000
262,400,000
262,900,000
196,000,000
196,200,000
196,400,000
198,000,000
197,000,000
196,600,000
195,700,000
194,200,000
226,200,000
228,600,000
228,900,000
229,500,000
228,900,000
231,500,000
231,700,000
231,900,000
309,500,000
315,500,000
359,300,000
390,700,000
371,300,000
381,100,000
394,700,000
428,400,000
378,800,000
362,100,000
296,400,000
294,900,000
299,300,000
323,300,000
367,200,000
364,700,000
358,100,000
369,300,000
356,800,000
348,300,000
379,100,000
393,000,000
386,300,000
384,000,000
382,100,000
382,000,000
397,700,000
417,000,000
394,600,000
393,100,000
384,200,000
376,600,000
235,800,000
240,600,000
259,300,000
270,600,000
280,700,000
260,200,000
277,300,000
152,700,000
150,800,000
162,400,000
153,200,000
148,600,000
167,000,000
162,700,000
164,100,000
160,700,000
159,200,000
172,000,000
172,000,000
171,400,000
184,300,000
195,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.